Affinia Therapeutics

Gene therapy player Affinia aims to go public, hoping to raise big money in effort to remake AAVs
Endpoints
Wed, 01/5/22 - 10:37 am
Affinia Therapeutics
IPOs
gene therapy
funding
Gene therapy funding frenzy reaches Affinia as it reels in $110M in new capital
MedCity News
Mon, 05/3/21 - 11:04 pm
Affinia Therapeutics
funding
gene therapy
Affinia secures $1.6bn worth deal from Vertex to develop AAV capsids for genetic therapies
Pharmaceutical Business Review
Tue, 04/28/20 - 10:51 am
Affinia Therapeutics
R&D
Vertex Pharmaceuticals
virus capsids
gene therapy